APOC3 and obesity due to melanocortin 4 receptor deficiency: Moreover, ApoC3 is extensively studied for potential use as a biomarker of disease, because changes in the ratio of its different glyco-isoforms occur in obesity, kidney disease, liver disease, and sepsis (44).